Diabetic Ketoacidosis and Profound Insulin Resistance From Brentuximab Vedotin

Hodgkin’s lymphoma is commonly treated with a combination of chemotherapy drugs including doxorubicin, bleomycin, vinblastine, and dacarbazine. Antibody-drug conjugates such as brentuximab vedotin are now being used to treat Hodgkin’s lymphoma that has not responded to standard treatment. Brentuxima...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Keval, Khurana, Sonali, Sun, Yujiao, Hembree, Timothy N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074015/
https://www.ncbi.nlm.nih.gov/pubmed/37025732
http://dx.doi.org/10.7759/cureus.35804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074015/
https://www.ncbi.nlm.nih.gov/pubmed/37025732
http://dx.doi.org/10.7759/cureus.35804

Ejemplares similares